Perianal Paget's disease as spread from non-invasive colorectal adenomas.
adenoma
extramammary Paget’s disease
perianal Paget’s disease
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
22
05
2020
revised:
22
06
2020
accepted:
20
07
2020
pubmed:
25
7
2020
medline:
28
9
2021
entrez:
25
7
2020
Statut:
ppublish
Résumé
Paget's disease of the perianal skin is a rare form of extramammary Paget's disease, and may be a primary intraepithelial adnexal neoplasm or secondary due to spread from an underlying colorectal lesion, nearly always colorectal adenocarcinoma. Secondary perianal Paget's disease associated with non-invasive colorectal adenomas is exceedingly uncommon, with only a few reported cases. Herein, we present the clinical and pathological features of the largest series of secondary perianal Paget's disease arising in association with colorectal adenomas. There was gender parity and the median age was 72 years (range = 68-76 years). In all cases, perianal Paget's disease was associated with colorectal adenomas, including three (75%) conventional tubular adenomas and one (25%) tubulovillous adenoma with serrated foci. All adenomas had high-grade dysplasia and one had intramucosal adenocarcinoma (lamina propria invasion; Tis), but all lacked submucosal invasion. The intraepithelial Paget's cells showed a colorectal phenotype by immunohistochemistry in all cases. At follow-up, two patients had no evidence of disease at 6 and 87 months, one had residual perianal Paget's disease at 8 months and one developed invasive adenocarcinoma of the perianal tissue at 36 months. Similar to its mammary analogue, secondary perianal Paget's disease may arise in association with invasive and/or in-situ colorectal lesions. Although the latter is an uncommon presentation of a recognised rare disease, knowledge of this phenomenon is important to forestall overdiagnosis of invasion and potential overtreatment. The clinical course is variable, such that close follow-up is required.
Identifiants
pubmed: 32705713
doi: 10.1111/his.14218
pmc: PMC9257882
mid: NIHMS1820780
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
276-280Subventions
Organisme : NCI NIH HHS
ID : T32 CA193145
Pays : United States
Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Am J Surg Pathol. 1998 Feb;22(2):170-9
pubmed: 9500217
Gastroenterology Res. 2016 Dec;9(6):99-102
pubmed: 28058078
Hematol Oncol Clin North Am. 2019 Feb;33(1):73-85
pubmed: 30497678
Cancer Med. 2018 Jun;7(6):2307-2318
pubmed: 29722170
Breast Cancer Res Treat. 2013 Aug;141(1):1-12
pubmed: 23929251
BJOG. 2005 Mar;112(3):273-9
pubmed: 15713139
Cancer. 1963 Mar;16:387-403
pubmed: 13953662
Int J Surg Pathol. 2009 Feb;17(1):42-5
pubmed: 18499687
Br J Surg. 1989 Jan;76(1):60-3
pubmed: 2537129
Int J Colorectal Dis. 1992 Sep;7(3):167-9
pubmed: 1328429
Int J Colorectal Dis. 2008 Nov;23(11):1125-30
pubmed: 18535830
J Clin Pathol. 1973 Jan;26(1):25-31
pubmed: 4540378
Arch Pathol Lab Med. 1998 Dec;122(12):1077-81
pubmed: 9870855
Diagn Pathol. 2020 Mar 24;15(1):29
pubmed: 32209119
Int J Colorectal Dis. 2016 Jan;31(1):29-34
pubmed: 26260479
Histopathology. 2017 Feb;70(3):466-472
pubmed: 27676454
Histopathology. 2002 Aug;41(2):177-9
pubmed: 12147102
Br J Dermatol. 2005 Sep;153(3):677-9
pubmed: 16120171